Business
Currency:USD
2024/Q2
Stock NameRevenueRatio
FILSPARI27.13M50.12%
Tiopronin products25.05M46.29%
License and collaboration revenue1.94M3.58%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States145.24M100.00%